pCR in breast and lymph nodal status
NeoSphere
TH
(n=107)
THP
(n=107)
HP
(n=107)
TP
(n=96)
pCR in the breast, %
29.0
45.8
16.8
24.0
pCR and N- at surgery, %
21.5
39.3
11.2
17.7
pCR and N+ at surgery, %
7.5
6.5
5.6
6.3
pCR, pathological complete response; N, node
H, trastuzumab; P, pertuzumab; T, docetaxel
Gianni L. et al. Lancet Oncol 2012
